Try our Advanced Search for more refined results

FDA Shifts To More Cautious Stance On BPA

By Tina Peng (January 15, 2010, 3:40 PM EST) -- The U.S. Food and Drug Administration announced Friday that it will work to reduce infants' exposure to controversial chemical bisphenol A and support a more robust regulatory framework for the chemical, responding to concerns about BPA's potential effects on the brain, behavior and prostate gland in fetuses, infants and children....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!